EUDAMED Compliance Guide for Device Manufacturers

Understanding EUDAMED, UDI and Device Registration

Overview

The European Union Medical Device Regulation (EU MDR 2017/745) and In Vitro Diagnostic Medical Device Regulation (EU IVDR 2017/746) introduced EUDAMED as the European Commission’s centralized database for managing regulatory information throughout the medical device lifecycle. For manufacturers, EUDAMED plays a critical role in registering Economic Operators, devices, certificates, and other regulatory information required to support market access within the European Union.

One of the primary responsibilities under MDR and IVDR is submitting accurate UDI device information to the EUDAMED UDI/Devices module. Successful compliance depends on maintaining complete, accurate, and up-to-date regulatory data throughout the product lifecycle.

Why EUDAMED Was Introduced

EUDAMED was established to improve traceability, transparency, and regulatory oversight of medical devices across the European Union. By providing a centralized platform for regulatory information, it enables Competent Authorities, Notified Bodies, manufacturers, care providers, and other stakeholders to access consistent device information while supporting market surveillance, vigilance, and patient safety.

Understanding the Role of UDI

The Unique Device Identification (UDI) system provides standardized identifiers that uniquely distinguish medical devices throughout their lifecycle. Under MDR and IVDR, manufacturers are required to assign UDI identifiers to applicable devices and register associated device information within EUDAMED.

Together, UDI and EUDAMED support:

• Product traceability.
• More efficient recalls and field safety corrective actions.
• Improved post-market surveillance.
• Greater consistency of medical device data across Europe.

Understanding the EUDAMED Modules

EUDAMED consists of six interconnected modules that support different aspects of the regulatory lifecycle.

Although all modules contribute to regulatory compliance, this guide focuses on the UDI/Devices module and the activities required to successfully submit and maintain compliant device records.

Current Implementation Status

EUDAMED is being introduced through a phased implementation approach, allowing several modules to be used before mandatory compliance dates take effect. Manufacturers can use this transition period to improve data quality, establish governance processes, and prepare submission workflows before mandatory requirements apply.

Key Takeaway

Understanding how EUDAMED and UDI work together is the foundation of MDR and IVDR compliance. While submitting device records is a key regulatory obligation, successful compliance ultimately depends on trusted product data, effective governance, and well-defined submission processes that support accurate registrations throughout the product lifecycle.

Understanding the EUDAMED Data Model

Overview

Successful EUDAMED submissions depend on more than collecting the relevant product information. Manufacturers must understand how medical devices are represented within the EUDAMED data model and how different regulatory identifiers and device records relate to one another. A clear understanding of these relationships helps organizations prepare accurate submissions, maintain data consistency, and determine when changes to a device require updates to existing records or the creation of new identifiers.

Core Device Identifiers

The EUDAMED data model is built around two primary regulatory identifiers:

• Basic UDI-DI – The primary regulatory identifier that groups devices sharing the same intended purpose, risk class, and essential design and manufacturing characteristics. It links the device family to the Declaration of Conformity, technical documentation, and regulatory certificates.
• UDI-DI – The product-specific identifier that uniquely identifies a particular device model or version. The UDI-DI appears on the product label and is registered within EUDAMED as part of the device record.

A single Basic UDI-DI may be associated with multiple UDI-DIs where products belong to the same device family but differ in model, configuration, or packaging.

Packaging Hierarchies and Device Relationships

Manufacturers must also represent how devices are packaged and supplied to the market. Individual devices, higher packaging levels, and system or procedure packs may each require their own identifiers depending on how they are marketed.

Accurately defining these relationships ensures that EUDAMED reflects the actual product configurations available to customers and supports effective product traceability throughout the supply chain.

Issuing Entities and Identifier Standards

UDI identifiers must be issued using one of the European Commission’s designated issuing entities, including:

• GS1
• HIBCC
• ICCBBA
• IFA

Each issuing entity uses its own coding structure while complying with the MDR and IVDR requirements for globally unique device identification. Manufacturers should consistently apply a single issuing standard across their product portfolio wherever practical.

When Device Identifiers Need to Change

Not every product change requires a new device identifier. However, certain modifications—such as changes affecting the device’s intended purpose, model, safety characteristics, or regulatory classification—may require a new UDI-DI or, in some cases, a new Basic UDI-DI.

Understanding these trigger points helps manufacturers maintain accurate regulatory records while avoiding unnecessary identifier changes or non-compliant submissions.

Key Takeaway

Understanding the EUDAMED data model is fundamental to successful device registration. By correctly managing Basic UDI-DIs, UDI-DIs, packaging hierarchies, and device relationships, manufacturers can establish a consistent regulatory data structure that supports accurate submissions, efficient lifecycle management, and long-term compliance.

Preparing Device Data for Submission

Overview

The quality of a EUDAMED submission depends on the quality of the underlying device data. Before manufacturers can successfully register devices, they must ensure that all required regulatory information is complete, accurate, and sourced from trusted enterprise systems. Preparing submission-ready device data often requires consolidating product information from multiple departments, validating against UDI database rules, and resolving data quality issues before submission.

Understanding Required Device Data

EUDAMED requires manufacturers to submit a broad range of device information beyond the Basic UDI-DI and UDI-DI identifiers. Depending on the device and applicable regulations, submissions may include identifiers, device descriptions, regulatory classifications, certificates, packaging information, EMDN codes, economic operator details, and other mandatory attributes defined within the MDR and IVDR.

Understanding which attributes are required—and how they relate to one another—is essential for preparing complete and compliant submissions.

Identifying Data Sources and Ownership

The information required for EUDAMED rarely resides in a single system. Device data is often distributed across Product Lifecycle Management (PLM), Enterprise Resource Planning (ERP), Regulatory Information Management (RIM), Quality Management Systems (QMS), labeling systems, and other enterprise applications.

Establishing clear ownership for each regulatory data element helps improve accountability, supports data governance, and ensures that submitted device information remains consistent across enterprise systems.

Assessing Data Quality and Completeness

Before preparing UDI submissions, manufacturers should perform a data readiness assessment to identify missing, inconsistent, or outdated information. Common issues include incomplete mandatory attributes, inconsistent product descriptions, incorrect classifications, duplicate records, and conflicting information between source systems.

Resolving these issues before submission reduces data validation errors, minimizes rework, and improves the efficiency of ongoing regulatory operations.

Preparing a Trusted Submission Dataset

Once device data has been reviewed and validated, manufacturers should establish a controlled submission dataset that serves as the authoritative source for EUDAMED submissions. This dataset should align with approved product labels, technical documentation, declarations of conformity, and internal regulatory records to ensure consistency throughout the submission lifecycle.

Key Takeaway

High-quality UDI submissions begin with high-quality device data. By identifying trusted data sources, assigning ownership, assessing data quality, and preparing a controlled submission dataset, manufacturers can significantly reduce submission errors while establishing a strong foundation for efficient and sustainable EUDAMED compliance.

EUDAMED Access and Submission Methods

Overview

Before manufacturers can submit device information to EUDAMED, they must complete a series of regulatory, administrative, and technical activities that establish secure access to the European Commission’s systems. These prerequisites include registering as an Economic Operator, obtaining the appropriate user permissions, configuring secure connectivity for automated submissions, and selecting the submission method that best aligns with the organization’s regulatory operations.

Completing these activities early helps avoid implementation delays and provides a solid foundation for both initial device registrations and ongoing lifecycle management.

Registering as an Economic Operator

The first step in accessing EUDAMED is registering as an Economic Operator through the Actor Registration module. During this process, manufacturers submit organizational information to the relevant National Competent Authority for verification.

Once approved, the organization receives a Single Registration Number (SRN), which serves as its unique regulatory identifier within EUDAMED. The SRN is required before device information can be registered and is used throughout EUDAMED to associate manufacturers with device records, certificates, vigilance reports, and other regulatory information.

Manufacturers should complete Actor Registration as early as possible, as approval timelines vary between Member States and delays may affect downstream registration activities.

Configuring User Roles and Permissions

After obtaining an SRN, manufacturers must establish the appropriate user access within EUDAMED.

EUDAMED uses a hierarchical role-based access model to ensure that only authorized individuals can manage regulatory information.

Each manufacturer must appoint a Local Actor Administrator (LAA), who is responsible for managing the organization’s EUDAMED account. The LAA administers the organization’s profile, manages user accounts, assigns permissions, and controls access to the various EUDAMED modules.

The LAA may appoint one or more Local User Administrators (LUAs) to assist with user administration. Individual users can then be assigned permissions appropriate to their responsibilities, such as preparing device records, reviewing submissions, approving regulatory information, or monitoring submission status.

Clearly defined user roles support segregation of duties, strengthen governance, and help maintain the integrity of regulatory information throughout the submission process.

Establishing Machine-to-Machine Connectivity

Organizations intending to automate device submissions must complete additional onboarding activities before production submissions can begin.

Unlike manual data entry, Machine-to-Machine (M2M) communication requires manufacturers to establish secure system-to-system connectivity with EUDAMED and complete the onboarding process defined by the European Commission.

This typically includes:

• Configuring the organization’s EUDAMED environment to permit automated submissions.
• Registering the required technical information for secure message exchange.
• Validating XML message structures and submission workflows.
• Testing connectivity within the EUDAMED Playground environment before requesting Production access.

Completing comprehensive testing helps identify technical issues before live submissions begin and reduces implementation risk during production deployment.

Configuring eDelivery and AS4 Messaging

Machine-to-Machine communication with EUDAMED uses the European Commission’s eDelivery framework, which exchanges XML messages using the AS4 messaging protocol.

To participate in automated submissions, manufacturers require access to a certified eDelivery Access Point capable of securely transmitting and receiving regulatory messages.

Organizations generally have two options:

• Deploy and maintain their own certified AS4 Access Point.
• Use a certified third-party Access Point provider to manage secure connectivity.

While operating an internal Access Point provides greater control, it also requires specialist expertise to deploy, monitor, secure, and maintain the AS4 infrastructure. Many manufacturers therefore choose a certified third-party provider to reduce technical complexity while ensuring reliable communication with EUDAMED.

Regardless of the chosen approach, organizations should verify successful message transmission, acknowledgement processing, and security configuration before commencing production submissions.

Selecting the Appropriate Submission Method

Once access has been established, manufacturers must determine how device information will be submitted to EUDAMED. The most appropriate approach depends on submission volumes, internal resources, system maturity, and long-term operational objectives.

Organizations should also consider future growth when selecting a submission method. Although manual submission may satisfy immediate requirements, increasing product portfolios and ongoing lifecycle updates often make automated M2M submissions more efficient over time.

Best Practices

Successful onboarding begins well before the first device submission. Manufacturers should:

• Complete Economic Operator Registration early.
• Clearly define administrator and user responsibilities.
• Perform comprehensive testing within the Playground environment.
• Validate XML messages before production.
• Verify acknowledgement processing and error handling.
• Select a submission approach that supports future regulatory growth.

Key Takeaway

Obtaining access to EUDAMED involves more than creating user accounts. Manufacturers must establish their regulatory identity, configure secure user access, complete technical onboarding for automated submissions where applicable, and select a submission method that aligns with their long-term regulatory strategy. Completing these activities thoroughly helps establish a secure, scalable, and efficient submission environment.

Best Practice Device Submission Process

Overview

Submitting device information to EUDAMED should follow a controlled, repeatable process that ensures regulatory data is accurate before it is transmitted, validated during processing, and maintained after registration. Establishing standardized submission workflows reduces errors, improves operational efficiency, and supports long-term regulatory compliance.

Although the technical submission method may differ between manual entry, XML upload, and Machine-to-Machine (M2M) communication, the underlying business process remains largely the same.

Step 1: Prepare Submission Data

The submission process begins by collecting all regulatory information required for device registration.

Manufacturers should ensure that device identifiers, classifications, packaging information, certificates, EMDN codes, economic operator details, and other mandatory attributes have been completed using approved source data.

Any missing or inconsistent information should be resolved before progressing to the next stage.

Step 2: Validate Device Information

Before submission, manufacturers should perform comprehensive data validation to confirm that device information satisfies both regulatory and technical requirements.

Validation activities should verify:

• Mandatory attributes are complete.
• Identifier formats are valid.
• Code lists use approved values.
• Packaging hierarchies are consistent.
• Relationships between Basic UDI-DIs and UDI-DIs are correct.
• XML messages comply with EUDAMED specifications.

Performing data validation before submission significantly reduces processing errors and minimizes resubmissions.

Step 3: Review and Approve Regulatory Data

Regulatory information should undergo an internal review before submission.

Organizations should establish documented approval workflows to verify that submitted information accurately reflects approved product documentation, declarations of conformity, certificates, and labeling information.

Formal approvals strengthen governance and reduce the risk of unauthorized or inaccurate submissions.

Step 4: Submit Device Information

Once approved, manufacturers can submit device information using the selected submission method.

Depending on the organization’s implementation, submissions may occur through:

• Manual data entry.
• XML bulk upload.
• Automated Machine-to-Machine (M2M) integration.

Regardless of the submission method, organizations should ensure that submitted device data corresponds to the approved regulatory dataset.

Step 5: Review Validation Responses

Following submission, EUDAMED validates incoming information and returns acknowledgement and validation messages.

Manufacturers should review these responses promptly to confirm that:

• Submissions were successfully received.
• Business rules have been satisfied.
• No validation errors require corrective action.
• Device records have been successfully processed.

Timely review enables issues to be resolved before they delay product registrations.

Step 6: Correct and Resubmit Where Required

If validation errors occur, manufacturers should investigate the underlying cause before resubmitting corrected information.

Rather than correcting isolated records, organizations should determine whether similar issues affect other products or originate from upstream enterprise systems.

Addressing root causes improves future submission quality while reducing repetitive errors.

Step 7: Maintain Registered Device Information

The submission process does not end once a device has been successfully registered.

Manufacturers should establish ongoing processes to maintain EUDAMED records whenever product information changes, including updates to certificates, packaging configurations, classifications, economic operator information, or other reportable regulatory data.

Maintaining accurate device records throughout the product lifecycle is essential for sustained UDI compliance.

Best Practices

An effective UDI submission process should:

• Use approved source data only.
• Validate device information before submission.
• Require documented regulatory approval.
• Monitor acknowledgements and validation responses.
• Investigate root causes rather than isolated errors.
• Maintain complete submission histories and audit trails.
• Update EUDAMED promptly following reportable product changes.

Key Takeaway

Successful EUDAMED submissions rely on disciplined, repeatable processes rather than individual submission events. By following a structured workflow that includes data preparation, validation, approval, submission, monitoring, corrective action, and lifecycle maintenance, manufacturers can improve submission quality, reduce regulatory risk, and establish sustainable UDI compliance practices.

Data Validation, Error Handling and Submission Monitoring

Overview

Submitting device information to EUDAMED is only one part of the registration process. Each submission is validated against a comprehensive set of technical, business, and regulatory rules before it is accepted into the database. Manufacturers must be able to identify validation issues, understand regulator responses, correct errors efficiently, and monitor submission progress to ensure device records are successfully registered.

Implementing structured validation and monitoring processes improves submission quality, reduces delays, and enables organizations to maintain accurate and up-to-date device information throughout the product lifecycle.

Validating Device Data Before Submission

Many submission issues can be prevented by validating device information before it is transmitted to EUDAMED. Manufacturers should verify that all mandatory attributes have been completed, code values are valid, identifiers are correctly formatted, packaging hierarchies are consistent, and relationships between data elements comply with EUDAMED business rules.

Pre-submission data validation helps identify potential issues early, allowing corrections to be made before submissions are processed by EUDAMED. This reduces the likelihood of rejected submissions, minimizes rework, and improves overall submission efficiency.

Understanding Validation Responses

Following submission, EUDAMED validates incoming XML messages and returns acknowledgements indicating whether the submission has been successfully processed or whether issues require attention.

Validation responses may identify:

• Missing mandatory information.
• Invalid attribute values or code lists.
• Incorrect identifier formats.
• Inconsistent relationships between data elements.
• Business rule violations.
• Technical processing errors.

Manufacturers should review these responses promptly to determine whether corrective action is required before resubmitting device information.

Managing Errors and Corrective Actions

Validation errors should be investigated systematically to identify both the immediate cause and any underlying data quality or process issues.

Rather than simply correcting individual records, organizations should determine whether similar issues exist across other products or originate from upstream source systems. Addressing root causes helps prevent recurring errors and improves the quality of future submissions.

Establishing defined procedures for reviewing validation results, assigning corrective actions, and approving resubmissions helps reduce delays while supporting consistent regulatory processes.

Monitoring Submission Status

Manufacturers should maintain visibility over the status of every submission throughout its lifecycle.

Monitoring should extend beyond confirming that a submission was transmitted successfully. Organizations should also verify that submissions have progressed through each stage of processing, acknowledgements have been received, validation issues have been resolved, and device records have been successfully registered within EUDAMED.

Maintaining complete submission visibility enables Regulatory Affairs teams to quickly identify delayed or failed submissions and prioritize corrective action where necessary.

Maintaining a Complete Submission History

Maintaining a comprehensive history of submission activities supports both operational management and regulatory compliance.

Organizations should retain records of submitted XML messages, acknowledgement responses, validation outcomes, error corrections, resubmissions, approval activities, and submission timestamps. A complete audit trail provides evidence of regulatory activities, simplifies investigations, and supports internal audits and regulatory inspections.

Historical submission information also enables organizations to identify recurring data validation issues, measure submission performance, and continuously improve regulatory processes.

Key Takeaway

Effective EUDAMED compliance extends beyond transmitting device data. By validating information before submission, responding quickly to validation messages, managing corrective actions systematically, monitoring submission progress, and maintaining a complete submission history, manufacturers can improve submission success rates while establishing a reliable and sustainable regulatory submission process.

System Quality, Validation and Security Requirements

Overview

Successfully submitting device information to EUDAMED requires more than accurate regulatory data. Manufacturers must also ensure that the systems and processes supporting submissions meet appropriate quality, security, and compliance standards. Regulatory submissions form part of an organization’s quality management system and should be supported by secure, validated, and well-governed software that protects data integrity throughout the submission lifecycle.

Implementing appropriate controls helps manufacturers reduce regulatory risk, maintain confidence in submitted data, and demonstrate compliance during audits and inspections.

Supporting Data Integrity

Data integrity is fundamental to regulatory compliance. Manufacturers must be able to demonstrate that submitted information is complete, accurate, attributable, and protected from unauthorized modification throughout its lifecycle.

This requires controls that ensure:

• Device information originates from trusted and approved sources.
• Changes to regulatory data are controlled and traceable.
• Submitted information accurately reflects approved product documentation.
• Historical submission records remain available for review.
• Regulatory data is protected from unauthorized access or alteration.

Maintaining strong data integrity practices helps ensure that regulators and internal stakeholders can rely on the accuracy of registered device information.

Computer System Validation

Systems used to prepare, approve, and submit regulatory information should be validated to demonstrate that they consistently perform as intended.

Manufacturers should adopt a risk-based validation approach that aligns with GAMP 5 (Good Automated Manufacturing Practice) principles, ensuring validation activities are proportionate to system complexity and patient risk.

Validation activities typically include:

• Defining documented user and functional requirements.
• Verifying system configuration and functionality.
• Testing critical business processes.
• Confirming interfaces and data exchanges operate correctly.
• Managing system changes through formal change control.
• Maintaining validation documentation throughout the system lifecycle.

Applying a structured validation methodology helps manufacturers maintain confidence in regulatory submission processes while supporting inspection readiness.

Electronic Records and Electronic Signatures

Where electronic records and approvals are used as part of the submission process, manufacturers should ensure that applicable regulatory requirements are addressed.

Organizations operating globally commonly evaluate their systems against:

• EU Annex 11, which establishes expectations for computerized systems used within pharmaceutical and medical device quality systems.
• 21 CFR Part 11, which defines requirements for electronic records and electronic signatures regulated by the U.S. Food and Drug Administration.

Although EUDAMED itself does not mandate compliance with these regulations, manufacturers frequently operate within global quality systems where adherence to these requirements supports consistent governance across multiple regulatory processes.

Key capabilities include:

• Secure user authentication.
• Role-based permissions.
• Electronic approval workflows.
• Audit trails for regulated activities.
• Protection of electronic records from unauthorized modification.

Security and Access Controls

Because UDI submissions contain controlled product information, manufacturers should implement appropriate security measures to protect confidentiality, integrity, and availability.

Good security practices include:

• Role-based access control.
• Multi-factor authentication where appropriate.
• Encryption of data in transit and at rest.
• Secure communication channels for automated submissions.
• Regular security monitoring and vulnerability management.
• Backup and disaster recovery procedures.

Organizations should also ensure that user access is reviewed periodically and that permissions are aligned with defined business responsibilities.

Audit Trails and Traceability

Manufacturers should maintain complete traceability throughout the submission lifecycle.

Comprehensive audit trails should capture activities such as:

• Creation and modification of UDI data.
• User approvals.
• Submission dates and times.
• Acknowledgement messages.
• Changes made following regulatory updates.

Maintaining complete traceability enables organizations to reconstruct submission activities during internal reviews, regulatory inspections, or investigations.

Independent Compliance and Security Assessments

Many manufacturers also evaluate whether software providers have undergone independent assessments of their quality and security practices.

Examples include:

• ISO 27001 certification for information security management.
• SOC 2 reports covering security and operational controls.
• 21 CFR Part 11 and Annex 11 compliance.
• GAMP 5 system validation principles.
• Independent quality or compliance assessments performed by recognized third-party organizations.

While these certifications do not replace an organization’s own quality responsibilities, they provide additional assurance regarding the security and operational maturity of the systems supporting regulatory submissions.

Key Takeaway

Reliable EUDAMED submissions depend on more than regulatory knowledge. They require secure, validated, and well-governed systems that protect data integrity throughout the submission lifecycle. By implementing risk-based system validation, maintaining robust security controls, supporting electronic records and audit trails, and following recognized quality standards such as GAMP 5, EU Annex 11, and 21 CFR Part 11, manufacturers can strengthen regulatory compliance while improving inspection readiness and confidence in their submission processes.

Data Governance and Lifecycle Management

Overview

EUDAMED compliance is an ongoing operational responsibility rather than a one-time regulatory project. Once device information has been registered, manufacturers must ensure that it remains accurate, complete, and aligned with changes to products, regulatory requirements, and supporting documentation. Effective data governance establishes the policies, processes, and responsibilities required to manage UDI data consistently throughout the device lifecycle.

By implementing strong governance practices, manufacturers can improve data quality, reduce compliance risk, and ensure that EUDAMED records remain current and reliable over time.

Establishing Data Ownership and Accountability

Successful governance begins with clearly defined ownership of regulatory data.

Although Regulatory Affairs is typically responsible for coordinating EUDAMED submissions, the information required for device registration often originates from multiple business functions, including Product Management, Research and Development, Engineering, Quality Assurance, Manufacturing, and Supply Chain.

Assigning data owners for specific regulatory attributes helps ensure accountability for maintaining accurate information and provides a clear process for reviewing and approving changes before they are submitted to EUDAMED.

Clearly documented roles and responsibilities also reduce uncertainty, improve collaboration between departments, and support more efficient regulatory operations.

Managing Changes Throughout the Device Lifecycle

Device information rarely remains static throughout a product’s commercial life. Manufacturers must establish processes to identify, assess, approve, and implement changes that affect previously submitted EUDAMED records.

Examples of changes that may require updates include:

• Device design or specification changes.
• Packaging or configuration updates.
• Certificate renewals, suspensions, or withdrawals.
• Manufacturer or economic operator information.
• Regulatory classifications or EMDN codes.
• Device discontinuations or market withdrawals.

Evaluating regulatory impacts before implementing product changes helps ensure that EUDAMED remains synchronized with approved product documentation and other enterprise systems.

Controlling Regulatory Data Changes

Changes to UDI data should follow formal governance processes rather than ad hoc updates.

Organizations should establish documented procedures for requesting, reviewing, approving, implementing, and verifying changes to device information before submissions are updated within EUDAMED.

Change control processes should ensure that:

• Proposed changes are reviewed by the appropriate stakeholders.
• Regulatory impacts are assessed before implementation.
• Supporting documentation is updated where required.
• Changes are validated before submission.
• Approved updates are reflected consistently across enterprise systems.

Formal change management reduces the risk of introducing inconsistent or inaccurate device data for UDI compliance.

Maintaining Data Consistency Across Enterprise Systems

The same regulatory information is often used across multiple enterprise applications, including PLM, ERP, RIM, QMS, labeling systems, and EUDAMED.

Manufacturers should establish governance processes that maintain consistency between these systems and minimize duplicate data maintenance. Defining authoritative data sources, synchronizing updates between systems, and periodically reconciling regulatory information help reduce discrepancies that could result in submission errors or regulatory findings.

Maintaining a single and trusted source for each regulatory data element also simplifies ongoing maintenance and improves overall data quality.

Monitoring Data Quality

Maintaining high-quality UDI data requires continuous monitoring rather than periodic reviews.

Manufacturers should regularly assess the completeness, accuracy, consistency, and timeliness of device information to identify issues before they affect regulatory submissions. Common monitoring activities include reviewing mandatory attributes, identifying incomplete records, detecting duplicate data, verifying code values, and monitoring submission success rates.

Tracking data quality over time enables organizations to identify recurring issues, improve upstream business processes, and strengthen overall governance.

Supporting Continuous Compliance

Governance processes should be designed to support ongoing UDI compliance rather than individual submission events.

Manufacturers should establish regular reviews of regulatory data, monitor changes to applicable MDR and IVDR requirements, evaluate the impact of new guidance, and ensure internal procedures remain aligned with evolving regulatory expectations.

Embedding governance into day-to-day operations helps organizations maintain compliant EUDAMED records while reducing the effort required to respond to future regulatory changes.

Key Takeaway

Effective EUDAMED compliance depends on strong data governance throughout the device lifecycle. By establishing clear ownership, implementing formal change control processes, maintaining consistency across enterprise systems, continuously monitoring data quality, and embedding governance into everyday operations, manufacturers can maintain accurate EUDAMED records while reducing compliance risk and supporting sustainable UDI submission processes.

Best Practices for Successful EUDAMED Compliance

Overview

Achieving and maintaining EUDAMED compliance requires more than meeting submission deadlines. Successful manufacturers establish repeatable processes, strong data governance, validated systems, and cross-functional collaboration that support accurate regulatory data throughout the product lifecycle. By adopting proven best practices, organizations can reduce regulatory risk, improve submission efficiency, and build a sustainable UDI compliance program that adapts to evolving regulatory requirements.

Treat EUDAMED as an Ongoing Business Process

EUDAMED compliance should not be viewed as a one-time implementation project. Device information continues to evolve throughout the product lifecycle, requiring manufacturers to maintain accurate records, manage changes promptly, and monitor regulatory obligations on an ongoing basis.

Embedding EUDAMED activities into day-to-day regulatory operations helps ensure compliance becomes part of normal business processes rather than a reactive effort driven by regulatory deadlines.

Establish Strong Data Governance

Accurate regulatory submissions begin with well-governed data.

Manufacturers should define ownership for regulatory data, establish standardized approval workflows, implement formal change control procedures, and ensure that UDI information remains consistent across enterprise systems.

Strong governance reduces duplicate effort, improves accountability, and helps maintain trusted device information throughout the organization.

Validate Device Data Before Submission

Preventing submission errors is significantly more efficient than correcting rejected submissions.

Manufacturers should implement pre-submission data validation processes that verify mandatory attributes, business rules, identifier formats, code lists, packaging hierarchies, and data relationships before information is transmitted to EUDAMED.

Early data validation improves submission quality, reduces processing delays, and minimizes the need for resubmissions.

Automate Where Appropriate

As product portfolios expand, manual submission processes become increasingly difficult to manage.

Organizations should evaluate opportunities to automate repetitive activities such as data validation, XML generation, submission processing, acknowledgement handling, status monitoring, and synchronization with enterprise systems.

Automation reduces manual effort, improves consistency, and enables Regulatory Affairs teams to focus on higher-value compliance activities.

Maintain Secure and Validated Systems

The systems supporting EUDAMED submissions should be secure, reliable, and appropriately validated.

Manufacturers should implement risk-based computer system validation, maintain comprehensive audit trails, enforce role-based access controls, and protect electronic records throughout the submission lifecycle. Adopting recognized practices such as GAMP 5, EU Annex 11, and 21 CFR Part 11 helps strengthen compliance within regulated environments.

Monitor Performance and Continuously Improve

Organizations should regularly measure the effectiveness of their EUDAMED processes using operational and quality metrics.

Examples include:

• Submission success rates.
• Data validation error trends.
• Data quality metrics.
• Audit findings.

Reviewing these indicators enables manufacturers to identify opportunities for improvement and strengthen regulatory processes over time.

Stay Aligned with Regulatory Changes

EUDAMED continues to evolve as additional modules become available, new functionality is introduced, and guidance documents are updated.

Manufacturers should actively monitor developments published by the European Commission, MDCG, and relevant Competent Authorities to understand how regulatory changes may affect submission processes, internal procedures, and device data requirements.

Regularly reviewing regulatory developments helps organizations remain compliant with UDI requirements while reducing the risk of unexpected implementation challenges.

Foster Cross-Functional Collaboration

Successful EUDAMED compliance depends on collaboration across multiple business functions. Regulatory Affairs, Quality Assurance, Product Management, Engineering, Manufacturing, Supply Chain, IT, and other stakeholders all contribute information that supports accurate device registrations.

Establishing clear communication channels, defined responsibilities, and shared governance processes helps ensure that regulatory information remains consistent, complete, and aligned across the organization.

Key Takeaway

Successful EUDAMED compliance is built on accurate data, well-defined processes, effective governance, secure and validated systems, and continuous improvement. Manufacturers that treat compliance as an ongoing operational capability—rather than a one-time regulatory obligation—are better positioned to improve submission quality, reduce compliance risk, and adapt efficiently as regulatory requirements continue to evolve.